Wuhan Hhd Supply Pharmaceutical Chemicals Tofacitinib Citrate 540737-29-9 for Rheumatoid Arthritis

Product Details
Customization: Available
Powder: Yes
Customized: Non-Customized
Diamond Member Since 2016

Suppliers with verified business licenses

Audited Supplier Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
Full Customization
The supplier provides full customization services
ODM Services
The supplier provides ODM services
Quality Assurance
The supplier provides quality assurance
to see all verified strength labels (17)
  • Wuhan Hhd Supply Pharmaceutical Chemicals Tofacitinib Citrate 540737-29-9 for Rheumatoid Arthritis
  • Wuhan Hhd Supply Pharmaceutical Chemicals Tofacitinib Citrate 540737-29-9 for Rheumatoid Arthritis
  • Wuhan Hhd Supply Pharmaceutical Chemicals Tofacitinib Citrate 540737-29-9 for Rheumatoid Arthritis
  • Wuhan Hhd Supply Pharmaceutical Chemicals Tofacitinib Citrate 540737-29-9 for Rheumatoid Arthritis
  • Wuhan Hhd Supply Pharmaceutical Chemicals Tofacitinib Citrate 540737-29-9 for Rheumatoid Arthritis
  • Wuhan Hhd Supply Pharmaceutical Chemicals Tofacitinib Citrate 540737-29-9 for Rheumatoid Arthritis
Find Similar Products

Basic Info.

Suitable for
Adult
Purity
>98%
Color
White
Grade
Pharmaceutical Grade
Transport Package
Alumininum Foli Bags
Specification
10g, 50g, 200g, 1kg, 5kg
Trademark
hhdpharm
Origin
China

Product Description


Wuhan HHD Supply Pharmaceutical Chemicals Tofacitinib Citrate 540737-29-9 for Rheumatoid Arthritis
 

Basic information:

Product Name Tofacitinib citrate
CAS  540737-29-9
MF C16H20N6O.C6H8O7
MW 504.497
EINCES 638-826-4
Assay 99%
Brand Name Golt Biotech
Appearance white powder
Storage Preserve in tight,light-resistant containers in a cool place
Shelf life  2 years when properly stored.
 

Usage:

(1).Tofacitinib citrate is a king of drugs developed by the US pharmaceutical company for treating rheumatoid arthritis, for the treatment of methotrexate inadequate response or intolerance to severe active rheumatoid arthritis (RA) in adult patients. Tofacitinib citrate is approved for the treatment of methotrexate inadequate response or intolerance to severe active rheumatoid joints arthritis (RA) in adult patients.

(2). It can be used as monotherapy or in combination with methotrexate or other non-biological disease-modifying antirheumatic drugs (the DMARD) in combination. This medicine should not be in combination with biological DMARD or strong immunosuppressants (such as cyclosporine and azathioprine) . Tofacitinib citrate is approved by the daily dose of 2 times, each time 5mg. Seven clinical trials evaluated the safety and efficacy of Tofacitinib citrate in moderate to severe active RA in adult patients. In all tests, compared with patients receiving placebo, patients receiving Tofacitinib citrate treatment showed significant improvement in clinical response and physical function.abbreviated as NAD+ and NADH respectively.
 

Wuhan Hhd Supply Pharmaceutical Chemicals Tofacitinib Citrate 540737-29-9 for Rheumatoid ArthritisWuhan Hhd Supply Pharmaceutical Chemicals Tofacitinib Citrate 540737-29-9 for Rheumatoid ArthritisWuhan Hhd Supply Pharmaceutical Chemicals Tofacitinib Citrate 540737-29-9 for Rheumatoid ArthritisWuhan Hhd Supply Pharmaceutical Chemicals Tofacitinib Citrate 540737-29-9 for Rheumatoid ArthritisWuhan Hhd Supply Pharmaceutical Chemicals Tofacitinib Citrate 540737-29-9 for Rheumatoid ArthritisWuhan Hhd Supply Pharmaceutical Chemicals Tofacitinib Citrate 540737-29-9 for Rheumatoid ArthritisWuhan Hhd Supply Pharmaceutical Chemicals Tofacitinib Citrate 540737-29-9 for Rheumatoid Arthritis

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier